{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:27:22Z","timestamp":1782030442393,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":280,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018764","name":"Semnan University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.curtheres.2024.100764","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T13:43:36Z","timestamp":1729086216000},"page":"100764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy of Adding Sitagliptin to Ongoing Metformin on Metabolic Profile, Triglyceride-Glucose Index, Vitamin D3, and Liver Tests in Patients Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1706-6212","authenticated-orcid":false,"given":"Habib","family":"Yaribeygi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Katsiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Mirmohammadkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges Sadat","family":"Tabaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.curtheres.2024.100764_bib0001","first-page":"S1","article-title":"Definition, classification and diagnosis of diabetes mellitus","volume":"130","author":"Schleicher","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.curtheres.2024.100764_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8609213","article-title":"Molecular mechanisms linking oxidative stress and diabetes mellitus","volume":"2020","author":"Yaribeygi","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.curtheres.2024.100764_bib0003","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2337\/dci18-0012","article-title":"The cost of diabetes care\u2014an elephant in the room","volume":"41","author":"Riddle","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.curtheres.2024.100764_bib0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mpdhp.2022.10.005","article-title":"Diagnosis and classification of vascular liver disorders","volume":"29","author":"Gonz\u00e1lez","year":"2023","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.curtheres.2024.100764_bib0005","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.3390\/ijms21113863","article-title":"Japan Study Group of NAFLD (JSG-NAFLD). The role of insulin resistance and diabetes in nonalcoholic fatty liver disease","volume":"21","author":"Fujii","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.curtheres.2024.100764_bib0006","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.3390\/jcm12175597","article-title":"Nonalcoholic fatty liver disease in patients with type 2 diabetes: screening, diagnosis, and treatment","volume":"12","author":"Ciardullo","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.curtheres.2024.100764_bib0007","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.curtheres.2024.100764_bib0008","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","article-title":"Management of NAFLD: a stage-based approach","volume":"13","author":"Rinella","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.curtheres.2024.100764_bib0009","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.curtheres.2024.100764_bib0010","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.26390","article-title":"Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?","volume":"58","author":"Kwok","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.curtheres.2024.100764_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117305","article-title":"The molecular mechanisms by which vitamin D improve glucose homeostasis: a mechanistic review","volume":"244","author":"Yaribeygi","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.curtheres.2024.100764_bib0012","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.3390\/ijms23169016","article-title":"Role of vitamin D in liver disease and complications of advanced chronic liver disease","volume":"23","author":"Ravaioli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.curtheres.2024.100764_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116776","article-title":"Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.curtheres.2024.100764_bib0014","doi-asserted-by":"crossref","first-page":"e00163","DOI":"10.1002\/edm2.163","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): a systematic review","volume":"3","author":"Lv","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.curtheres.2024.100764_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769069","article-title":"Efficacy and safety of GLP-1 receptor agonists in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.curtheres.2024.100764_bib0016","article-title":"Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.curtheres.2024.100764_bib0017","article-title":"A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes","volume":"9","author":"Doustmohammadian","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.curtheres.2024.100764_bib0018","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0035-1562942","article-title":"Diagnosis and assessment of NAFLD: definitions and histopathological classification","volume":"35","author":"Burt","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.curtheres.2024.100764_bib0019","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ypmed.2016.01.022","article-title":"Triglyceride\u2013glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: the vascular-metabolic CUN cohort","volume":"86","author":"Navarro-Gonz\u00e1lez","year":"2016","journal-title":"Prev Med"},{"key":"10.1016\/j.curtheres.2024.100764_bib0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40261-016-0383-1","volume":"36","author":"Ohki","year":"2016","journal-title":"Clini Drug Investig"},{"key":"10.1016\/j.curtheres.2024.100764_bib0021","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.6061\/clinics\/2019\/e736","article-title":"Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes","volume":"74","author":"Shi","year":"2019","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.curtheres.2024.100764_bib0022","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12876-022-02615-0","article-title":"Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals","volume":"22","author":"Deng","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.curtheres.2024.100764_bib0023","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12944-020-01326-3","article-title":"Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study","volume":"19","author":"Zou","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.curtheres.2024.100764_bib0024","doi-asserted-by":"crossref","first-page":"e24940","DOI":"10.1097\/MD.0000000000024940","article-title":"Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"100","author":"Zhou","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.curtheres.2024.100764_bib0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2147\/DMSO.S203937","article-title":"Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women","volume":"12","author":"Albracht-Schulte","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.curtheres.2024.100764_bib0026","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.18295\/squmj.2016.16.02.002","article-title":"Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation","volume":"16","author":"Mohamed","year":"2016","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1016\/j.curtheres.2024.100764_bib0027","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.3390\/jcm11133649","article-title":"The role of insulin resistance in fueling NAFLD pathogenesis: from molecular mechanisms to clinical implications","volume":"11","author":"Palma","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.curtheres.2024.100764_bib0028","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.14309\/00000434-201210001-00393","article-title":"Elevated fasting serum glucose in non-alcoholic fatty liver disease (NAFLD) patients is correlated with the degree of steatosis","volume":"107","author":"Estep","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.curtheres.2024.100764_bib0029","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2459\/JCM.0000000000001270","article-title":"Effects of sitagliptin on serum lipid levels in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"23","author":"Wu","year":"2022","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.curtheres.2024.100764_bib0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11883-022-01028-4","article-title":"Management of dyslipidemia in patients with non-alcoholic fatty liver disease","volume":"24","author":"Martin","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.curtheres.2024.100764_bib0031","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/14656566.2017.1351946","article-title":"Cardiovascular disease prevention strategies for type 2 diabetes mellitus","volume":"18","author":"Katsiki","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.curtheres.2024.100764_bib0032","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.metabol.2017.02.014","article-title":"The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An expert panel statement","volume":"71","author":"Athyros","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.curtheres.2024.100764_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270143","article-title":"Effect of different antidiabetic medications on atherosclerotic cardiovascular disease (ASCVD) risk score among patients with type-2 diabetes mellitus: a multicenter non-interventional observational study","volume":"17","author":"Gillani","year":"2022","journal-title":"PLos One"},{"key":"10.1016\/j.curtheres.2024.100764_bib0034","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.arr.2015.07.008","article-title":"The new insight on the regulatory role of the vitamin D3 in metabolic pathways characteristic for cancerogenesis and neurodegenerative diseases","volume":"24","author":"Kubis","year":"2015","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.curtheres.2024.100764_bib0035","doi-asserted-by":"crossref","first-page":"G542","DOI":"10.1152\/ajpgi.00286.2019","article-title":"Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD","volume":"318","author":"Zeng","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.curtheres.2024.100764_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1101516","article-title":"The association of vitamin D status with oxidative stress biomarkers and matrix metalloproteinases in patients with knee osteoarthritis","volume":"10","author":"Amirkhizi","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.curtheres.2024.100764_bib0037","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1210\/jc.2014-2136","article-title":"Clinical review: effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis","volume":"99","author":"Seida","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.curtheres.2024.100764_bib0038","doi-asserted-by":"crossref","first-page":"S975","DOI":"10.1016\/j.dsx.2017.07.025","article-title":"The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Tabrizi","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.curtheres.2024.100764_bib0039","first-page":"23","article-title":"Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial","volume":"10","author":"Alam","year":"2018","journal-title":"Hepat Med"},{"key":"10.1016\/j.curtheres.2024.100764_bib0040","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/s41598-022-05766-y","article-title":"The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults","volume":"12","author":"Kathak","year":"2022","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"10.1016\/j.curtheres.2024.100764_bib0041","first-page":"S24","article-title":"Dietary patterns in non-alcoholic fatty liver disease (NAFLD): stay on the straight and narrow path!","volume":"34","author":"Katsiki","year":"2022","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.curtheres.2024.100764_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106679","article-title":"Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): a position paper from the International Lipid Expert Panel (ILEP)","volume":"189","author":"Rizzo","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.curtheres.2024.100764_bib0043","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s42000-022-00379-6","article-title":"Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer","volume":"21","author":"Polyzos","year":"2022","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.curtheres.2024.100764_bib0044","doi-asserted-by":"crossref","DOI":"10.1177\/10742484221146371","volume":"27","author":"Muzurovi\u0107","year":"2022","journal-title":"J Cardiovasc Pharmacol Ther"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T09:09:12Z","timestamp":1734167352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X24000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":44,"alternative-id":["S0011393X24000341"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100764","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Adding Sitagliptin to Ongoing Metformin on Metabolic Profile, Triglyceride-Glucose Index, Vitamin D3, and Liver Tests in Patients Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100764"}}